39 related articles for article (PubMed ID: 38587686)
1. [Anatomical structure and morphometric parameters of the distal segment of the lacrimal drainage system].
Atkova EL; Yartsev VD; Ekaterinchev MA
Vestn Oftalmol; 2024; 140(2. Vyp. 2):143-149. PubMed ID: 38739144
[TBL] [Abstract][Full Text] [Related]
2. Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patients.
Tucker N; Chow D; Stockl F; Codère F; Burnier M
Ophthalmology; 1997 Nov; 104(11):1882-6. PubMed ID: 9373121
[TBL] [Abstract][Full Text] [Related]
3. Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know.
Ali MJ
Ophthalmic Plast Reconstr Surg; 2016; 32(4):243-8. PubMed ID: 26866333
[TBL] [Abstract][Full Text] [Related]
4. Dynamic viscosity of the wall of the lacrimal sac in disorders of the patency of the lacrimal ducts.
Yartsev VD; Novikov IA; Atkova EL; Ekaterinchev MA
Int Ophthalmol; 2024 Apr; 44(1):171. PubMed ID: 38587686
[TBL] [Abstract][Full Text] [Related]
5. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
Yartsev VD; Atkova EL; Ekaterinchev MA
Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
[TBL] [Abstract][Full Text] [Related]
6. Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level.
Yartsev VD; Sheremeta MS; Trukhin AA; Atkova EL; Degtyarev MV; Yasyuchenya VS; Yudakov DV
Indian J Ophthalmol; 2023 May; 71(5):1828-1832. PubMed ID: 37203037
[TBL] [Abstract][Full Text] [Related]
7. Optimizing clinical outcomes for endoscopic lacrimal duct recanalization in patients with complete PANDO.
Javate RM
Int Ophthalmol; 2023 Jan; 43(1):175-184. PubMed ID: 35809164
[TBL] [Abstract][Full Text] [Related]
8. Morphological Characteristics of the Lacrimal Apparatus in its Obstruction of Various Genesis.
Demyashkin GA; Yartsev VD; Atkova EL; Ekaterinchev MA; Shchekin VI
Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):951-956. PubMed ID: 37206743
[TBL] [Abstract][Full Text] [Related]
9. Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
Makselis A; Petroska D; Kadziauskiene A; Jaruseviciene R; Ruzgys A; Cimbalas A; Besusparis J; Asoklis RS
BMC Ophthalmol; 2022 Jan; 22(1):12. PubMed ID: 34986808
[TBL] [Abstract][Full Text] [Related]
10. Dynamic mechanical characterization and viscoelastic modeling of bovine brain tissue.
Li W; Shepherd DET; Espino DM
J Mech Behav Biomed Mater; 2021 Feb; 114():104204. PubMed ID: 33218929
[TBL] [Abstract][Full Text] [Related]
11. Secondary Acquired Nasolacrimal Duct Obstruction as a Specific Complication of Treatment With Radioactive Iodine (Morphological Study).
Fedorov AA; Atkova EL; Yartsev VD
Ophthalmic Plast Reconstr Surg; 2020; 36(3):250-253. PubMed ID: 31743278
[TBL] [Abstract][Full Text] [Related]
12. Relationship between lacrimal sac size and duration of tearing in nasolacrimal duct obstruction.
Lee MJ; Kim IH; Choi YJ; Kim N; Choung HK; Khwarg SI
Can J Ophthalmol; 2019 Feb; 54(1):111-115. PubMed ID: 30851763
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of Ginseng on Salivary Dysfunction Following Radioiodine Therapy in a Mouse Model.
Kim JW; Kim JM; Kim SK; Kim YM; Choi JS
Thyroid; 2018 Aug; 28(8):1034-1041. PubMed ID: 29905085
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 for the Protection of Lacrimal Gland against High-Dose Radioiodine Therapy-Associated Oxidative Damage: Histopathologic and Tissue Cytokine Level Assessments in an Animal Model.
Yakin M; Eksioglu U; Sadic M; Koca G; Ozkan-Uney G; Yumusak N; Husniye Telek H; Demir A; Yazihan N; Ornek F; Korkmaz M
Curr Eye Res; 2017 Dec; 42(12):1590-1596. PubMed ID: 28937867
[TBL] [Abstract][Full Text] [Related]
15. Collagen/elastin hydrogels cross-linked by squaric acid.
Skopinska-Wisniewska J; Kuderko J; Bajek A; Maj M; Sionkowska A; Ziegler-Borowska M
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():100-108. PubMed ID: 26706512
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
